Huntington’s disease causes unintentional movements, as well as difficulty walking and controlling movements. Dementia, which is a decline in cognitive abilities, is part of Huntington’s disease. The ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal ...

ST. LOUIS — Scientists may have reached a breakthrough in the fight against Huntington’s disease, a rare and fatal inherited brain disorder with no cure. For the first time, a gene therapy has been ...

Genetic testing is the definitive diagnostic tool to identify the gene that causes Huntington’s disease, and you can have the genetic test years before symptoms begin. Huntington’s disease stage and ...

AUSTIN (KXAN) — An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia ...

UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. High-dose patients had 75% less progression over three years compared with standard care. uniQure ...

Researchers have found a new treatment for Huntington's disease, an inherited genetic brain disease that affects over 41,000 Americans, in breakthrough clinical trial that involved at least one ...

In a trial of people with early Huntington's, the newly developed therapy slowed the progression of symptoms by 75%. Reading time 3 minutes Doctors in the UK are claiming to have performed a ...

Amy Aungst, center right, organizes walks in Cape Henlopen, Delaware, to raise awareness about Huntington’s disease, a rare condition that is estimated to affect about 30,000 or more U.S. adults.

In a small trial, a gene therapy injected into the brain slowed the disease by 75 percent over three years. Huntington’s disease is extremely cruel. Symptoms start with random, uncontrollable twitches ...

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments, now in clinical trials, that target the whole protein but leave this ...